カテゴリ： MarketLine, デンマーク, 企業調査

ALK-Abello AS.：企業の戦略・SWOT・財務情報

◆英語タイトル：ALK-Abello AS. - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C15416
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：デンマーク
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

ALK-Abello AS. – Strategy, SWOT and Corporate Finance Report
Summary

ALK-Abello AS. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

ALK-Abello AS (ALK-Abello or ‘the company’) is a Denmark-based pharmaceutical company involved in the development and marketing of allergy treatment products in the form of injections, sublingual drops and sublingual tablets The company also produces an adrenaline auto-injector for the treatment of severe allergic reactions (anaphylaxis) and also manufactures products used in the diagnosis of allergies. The company operates across Europe, North America and other parts of the world. It is headquartered in Horsholm, Denmark.

Scope

- Detailed information on ALK-Abello AS. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting ALK-Abello AS. in the form of a SWOT analysis
- An in-depth view of the business model of ALK-Abello AS. including a breakdown and examination of key business segments
- Intelligence on ALK-Abello AS.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about ALK-Abello AS., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of ALK-Abello AS. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess ALK-Abello AS. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on ALK-Abello AS.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
ALK-Abello AS.: Company Overview
ALK-Abello AS.: Overview and Key Facts
ALK-Abello AS.: Overview
ALK-Abello AS.: Key Facts
ALK-Abello AS.: Key Employees
ALK-Abello AS.: Key Employee Biographies
ALK-Abello AS.: Major Products and Services
ALK-Abello AS.: Company History
ALK-Abello AS.: Management Statement
ALK-Abello AS.: Locations and Subsidiaries
ALK-Abello AS.: Key Competitors
ALK-Abello AS.: Company Analysis
ALK-Abello AS.: Business Description
ALK-Abello AS.: SWOT Analysis
ALK-Abello AS.: SWOT Overview
ALK-Abello AS.: Strengths
ALK-Abello AS.: Weaknesses
ALK-Abello AS.: Opportunities
ALK-Abello AS.: Threats
ALK-Abello AS.: Corporate Financial Deals Activity
ALK-Abello AS.: Financial Deals Overview
ALK-Abello AS.: Targets and Partners
ALK-Abello AS.: Top Deals 2015 – 2019YTD*
ALK-Abello AS.: Advisors
ALK-Abello AS.: Top Financial Advisors
ALK-Abello AS.: Mergers and Acquisitions
ALK-Abello AS.: Capital Raising
ALK-Abello AS.: Partnership
ALK-Abello AS.: Divestments
ALK-Abello AS.: Recent Developments
ALK-Abello AS.: News and Events Summary
ALK-Abello AS.: Business Expansion
ALK-Abello AS.: Contracts
ALK-Abello AS.: Corporate Governance
ALK-Abello AS.: Financial Performance
ALK-Abello AS.: Regulatory and Legal Events
ALK-Abello AS.: Research & Development
ALK-Abello AS.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: ALK-Abello AS.: Key Facts
Table 2: ALK-Abello AS.: Key Employees
Table 3: ALK-Abello AS.: Company History
Table 4: ALK-Abello AS.: Locations and Subsidiaries
Table 5: ALK-Abello AS.: Key Competitors
Table 6: ALK-Abello AS.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: ALK-Abello AS.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: ALK-Abello AS.: M&A Average Deal Size - Value (US$m)
Table 9: ALK-Abello AS.: Targets and Partners
Table 10: ALK-Abello AS.: Top Deals 2015 - 2019YTD*
Table 11: ALK-Abello AS.: Financial Advisor Ranking by Value (US$m)
Table 12: ALK-Abello AS.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 13: ALK-Abello AS.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 14: ALK-Abello AS.: Capital Raising by Deal Type (2015 - YTD*2019)
Table 15: ALK-Abello AS.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 16: ALK-Abello AS.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 17: ALK-Abello AS.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 18: ALK-Abello AS.: News and Events Summary
Table 19: ALK-Abello AS.: Business Expansion
Table 20: ALK-Abello AS.: Contracts
Table 21: ALK-Abello AS.: Corporate Governance
Table 22: ALK-Abello AS.: Financial Performance
Table 23: ALK-Abello AS.: Regulatory and Legal Events
Table 24: ALK-Abello AS.: Research & Development
Table 25: ALK-Abello AS.: Strategy and Operations

List of Figures
Figure 1: ALK-Abello AS.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: ALK-Abello AS.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: ALK-Abello AS.: M&A Average Deal Size - Value (US$m)
Figure 4: ALK-Abello AS.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: ALK-Abello AS.: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 6: ALK-Abello AS.: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 7: ALK-Abello AS.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 8: ALK-Abello AS.: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 9: ALK-Abello AS.: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[ALK-Abello AS.：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Leprino Foods Company：企業の戦略・SWOT・財務情報
    Leprino Foods Company - Strategy, SWOT and Corporate Finance Report Summary Leprino Foods Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Entertainment One Ltd.：企業の戦略・SWOT・財務分析
    Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report Summary Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bank of Japan (8301)：企業の財務・戦略的SWOT分析
    Bank of Japan (8301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Primoris Services Corp (PRIM)：石油・ガス：M&Aディール及び事業提携情報
    Summary Primoris Services Corp (Primoris) is a construction and infrastructure company. It provides construction, engineering, maintenance, replacement, fabrication, water and wastewater treatment services. In addition, it involves in the construction of mechanical facilities and structures such as …
  • Asda Stores Ltd：戦略・SWOT・企業財務分析
    Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • CCP Technologies Ltd (AGX)-製薬・医療分野：企業M&A・提携分析
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd is a biotechnology company that offers molecule drugs. The company develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of various diseases. It develops DiagnostIQ rapid point-of-care human diagnostic techno …
  • Avista Corp (AVA)：企業の財務・戦略的SWOT分析
    Avista Corp (AVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Reliance Communications Ltd (RCOM)：企業の財務・戦略的SWOT分析
    Reliance Communications Ltd (RCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • VeriSign Inc (VRSN)：企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Adient Plc (ADNT)：企業の財務・戦略的SWOT分析
    Adient Plc (ADNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Corgenix Medical Corp：医療機器：M&Aディール及び事業提携情報
    Summary Corgenix Medical Corp (Corgenix), a subsidiary of Orgentec Diagnostika GmbH is a medical device company that offers medical diagnostic solutions. The company offers vascular disease products, infectious disease products, non-invasive liver biomarkers, and instrumentation. It offers an instru …
  • Atrium Innovations Inc：企業の戦略的SWOT分析
    Atrium Innovations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Entersoft SA (ENTER)：企業の財務・戦略的SWOT分析
    Entersoft SA (ENTER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Garware Polyester Ltd (500655)：企業の財務・戦略的SWOT分析
    Garware Polyester Ltd (500655) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Jet Airways (India) Ltd.：企業の戦略・SWOT・財務情報
    Jet Airways (India) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jet Airways (India) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dana Incorporated：企業のM&A・事業提携・投資動向
    Dana Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Dana Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Nestle Purina PetCare Company：企業の戦略・SWOT・財務情報
    Nestle Purina PetCare Company - Strategy, SWOT and Corporate Finance Report Summary Nestle Purina PetCare Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Biofrontera AG (B8F)：企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Auswide Bank Ltd (ABA)：企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Forty Seven Inc (FTSV)：製薬・医療：M&Aディール及び事業提携情報
    Summary Forty Seven Inc (Forty Seven), formerly CD47 Sciences Inc is a clinical-stage immuno-oncology company that focuses on the development of therapies to treat cancer. The company’s lead molecule Hu5F9-G4 is a monoclonal antibody that is used against the CD47 receptor. Its monoclonal antibody is …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆